IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.550
AS - Asia 11.299
EU - Europa 9.211
SA - Sud America 2.564
AF - Africa 269
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 21
Totale 42.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.230
CN - Cina 3.890
SG - Singapore 3.741
UA - Ucraina 2.333
BR - Brasile 2.173
HK - Hong Kong 1.564
DE - Germania 1.395
IT - Italia 1.314
FR - Francia 819
FI - Finlandia 737
VN - Vietnam 726
PL - Polonia 549
IE - Irlanda 548
RU - Federazione Russa 469
GB - Regno Unito 464
TR - Turchia 439
IN - India 263
CA - Canada 148
AR - Argentina 147
BD - Bangladesh 135
SE - Svezia 126
NL - Olanda 101
IQ - Iraq 100
MX - Messico 99
ZA - Sudafrica 83
EC - Ecuador 79
ID - Indonesia 77
EE - Estonia 65
CZ - Repubblica Ceca 55
JP - Giappone 55
CO - Colombia 44
UZ - Uzbekistan 44
ES - Italia 40
PK - Pakistan 39
MA - Marocco 38
VE - Venezuela 38
SA - Arabia Saudita 33
BE - Belgio 32
PY - Paraguay 32
AT - Austria 30
TN - Tunisia 27
EG - Egitto 24
NG - Nigeria 24
EU - Europa 23
KE - Kenya 22
GR - Grecia 20
NP - Nepal 20
JO - Giordania 19
CL - Cile 18
AU - Australia 17
LT - Lituania 17
AZ - Azerbaigian 16
IL - Israele 16
AE - Emirati Arabi Uniti 14
DO - Repubblica Dominicana 13
MY - Malesia 13
PE - Perù 13
OM - Oman 12
PA - Panama 12
DZ - Algeria 11
JM - Giamaica 11
SN - Senegal 11
BY - Bielorussia 10
AL - Albania 9
BG - Bulgaria 9
BO - Bolivia 9
CH - Svizzera 9
IR - Iran 9
KG - Kirghizistan 9
KZ - Kazakistan 9
PH - Filippine 9
UY - Uruguay 9
DK - Danimarca 8
HU - Ungheria 8
TT - Trinidad e Tobago 8
CR - Costa Rica 7
HN - Honduras 7
LV - Lettonia 7
PT - Portogallo 7
TH - Thailandia 7
ET - Etiopia 6
KW - Kuwait 6
LA - Repubblica Popolare Democratica del Laos 6
MU - Mauritius 6
BB - Barbados 5
LB - Libano 5
RS - Serbia 5
KR - Corea 4
MK - Macedonia 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
AO - Angola 3
CI - Costa d'Avorio 3
KH - Cambogia 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
AM - Armenia 2
BW - Botswana 2
Totale 42.898
Salva come PNG Salva come JPEG
Città #
Singapore 1.939
Jacksonville 1.776
Fairfield 1.734
Ashburn 1.715
Woodbridge 1.598
Hong Kong 1.559
Houston 1.160
Ann Arbor 898
Princeton 804
Chandler 797
Cambridge 772
The Dalles 770
Beijing 725
Wilmington 696
Seattle 693
San Jose 619
Nanjing 575
Dublin 544
Warsaw 539
New York 457
Los Angeles 392
Lauterbourg 374
Helsinki 371
Istanbul 365
Dearborn 262
Ho Chi Minh City 243
Dallas 224
Nanchang 218
Buffalo 209
Des Moines 202
Moscow 198
São Paulo 196
Milan 188
Munich 168
Brescia 149
Changsha 149
Shenyang 137
Hanoi 130
Hebei 124
San Diego 121
Tianjin 120
Shanghai 118
Jinan 116
San Francisco 100
Council Bluffs 92
Orem 90
Jiaxing 88
Redondo Beach 76
Rio de Janeiro 75
Chicago 69
Kunming 65
Tallinn 65
Verona 64
London 62
Rome 61
Hangzhou 59
Dong Ket 56
Santa Clara 56
Boardman 50
Tokyo 50
Montreal 48
Zhengzhou 48
Brasília 46
Nuremberg 46
Turku 46
Washington 46
Belo Horizonte 44
Guangzhou 44
Chennai 43
Frankfurt am Main 42
Brooklyn 41
Denver 40
Tashkent 40
Lancaster 39
Toronto 39
Johannesburg 38
Brno 37
Quito 35
Curitiba 34
Jakarta 34
Ningbo 34
Haiphong 33
Lanzhou 33
Dhaka 32
Da Nang 31
Phoenix 31
Taizhou 31
Atlanta 30
Augusta 30
Brussels 30
Norwalk 29
Poplar 29
Porto Alegre 29
Baghdad 28
Manchester 28
Paris 28
Mexico City 27
Amsterdam 26
Boston 26
Pune 26
Totale 27.743
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 466
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 273
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 265
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 246
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 245
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 225
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 221
Pros-IT CNR: an Italian prostate cancer monitoring project 220
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 218
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 210
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 209
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 206
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 205
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 202
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 192
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 190
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 190
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 189
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 188
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 187
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 182
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 181
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 181
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 179
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 175
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 173
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 173
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 172
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 171
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 171
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 170
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 169
Role of external beam radiotherapy in the treatment of relapsing meningioma 169
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 167
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 165
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 165
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 164
GUROPA survey: genito-urinary radiation oncology prescription attitudes 162
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 161
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 161
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 161
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 160
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 160
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 160
From Molecular to Clinical Radiation Biology of Glioblastoma 159
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 159
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 156
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 156
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 155
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 155
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 154
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 154
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 153
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 153
"Radiotherapy versus combined modality in early stages", 152
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 152
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 150
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 150
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 150
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 148
Extreme hypofractionation for early prostate cancer: Biology meets technology 147
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 147
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 146
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 145
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 145
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 144
Cetuximab and Radiation Therapy in Head and Neck Cancer 142
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 142
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 141
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 139
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 138
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 138
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 138
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 138
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 138
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 138
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 137
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 137
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 136
Information Retrieval in Medicine: an Extensive Experimental Study 136
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 136
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 135
Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. 133
Duration of androgen suppression in the treatment of prostate cancer 133
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 133
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 132
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 132
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 132
18F-FDG-PET/CT in laryngeal cancer: Comparison with conventional imaging and prognostic role 131
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 130
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 129
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 129
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 128
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 128
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 128
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 128
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 128
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 127
Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients 126
Totale 16.544
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 211.100
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.190 0 0 0 0 0 0 0 0 0 469 521 200
2021/20222.635 143 487 46 104 44 137 112 210 154 304 229 665
2022/20232.471 448 133 71 160 171 635 8 235 302 142 83 83
2023/20242.896 131 48 251 128 116 528 90 116 824 65 81 518
2024/20256.439 44 80 35 797 818 555 712 183 556 511 1.291 857
2025/202611.956 1.167 1.911 1.114 2.160 1.100 751 1.753 454 837 709 0 0
Totale 43.448